ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
50 hedge funds and large institutions have $6.23M invested in Oncternal Therapeutics, Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 18 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 18
Holders
50
Holding in Top 10
–
Calls
$113K
Puts
$107K
Top Buyers
| 1 | +$156K | |
| 2 | +$155K | |
| 3 | +$104K | |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
+$78K |
| 5 |
SFM
Soros Fund Management
New York
|
+$54K |
Top Sellers
| 1 | -$904K | |
| 2 | -$560K | |
| 3 | -$488K | |
| 4 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$323K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$170K |